Des étudiants de la Luxembourg Tech School soutiennent les efforts de lutte contre la Covid-19

Veuillez noter qu’à l’exception du titre et du résumé, cet article est uniquement disponible en anglais.

• Département Infection & Immunité

Les élèves participant au concours de développement de jeux contribuent à la recherche sur les vaccins du LIH

Le vendredi 31 juillet, deux étudiants de la Luxembourg Tech School (LTS) ont fait don de 1 000 euros à l’équipe du professeur Markus Ollert du Luxembourg Health Insitute (LIH), afin de soutenir ses activités de développement d’un vaccin contre la Covid-19. Ce don a été fait par Antonio del Rio et Marco Brunacci, qui avaient obtenu le deuxième prix du concours « GameDev Challenge 2020 » de la LTS.

LTS is an extracurricular school programme aiming to encourage the training and education of the new generation of digital leaders aged 11 to 19. Founded in 2016, it has grown to include over 120 youngsters from 7 schools. In addition to weekly classes, LTS organises a series of activities and competitions to build and strengthen the students’ digital skills. One of these initiatives, the ‘GameDev Challenge 2020’, teaches participants to design and develop their own game through online resources and tutoring. Marco Brunacci and Antonio del Rio were awarded the second prize of the 2020 edition of the challenge, amounting to EUR 1,000, for their 3D space exploration game ‘Cosmic Raider’.

All winners of the Game Dev Challenge got an additional EUR 1,000 to donate to an organisation of their choice which is helping people affected by COVID-19. We are really proud that Antonio and Marco selected Prof Ollert’s vaccine-development project

says Ralph Marshall from LTS,

The study “RD-Vac SARS-CoV-2” (Rapid Development and Initial Preclinical Evaluation of an Effective Candidate Vaccine against SARS-CoV-2), which had recently been funded through a EUR 50,000 grant under the FNR’s COVID-19 Fast Track Call, aims to develop a vaccine based on the expression of recombinant SARS-CoV-2 antigenic variants in a novel trimeric form, combining antigen delivery with CpG oligodinucleotides adjuvant, which confers strong immune responses both in the young and the elderly. The goal is to develop a vaccine candidate in a six-month time frame, with the confirmed ability to induce a robust immune response in preclinical mouse models.

Following the cancellation of the final exams of the International Baccalaureate due to the COVID-19 pandemic, Marco and I were unexpectedly given the chance to participate in the Luxembourg Tech School (LTS) Online Unity GameDev challenge. This was a double satisfaction for us. Not only did we win the second place in the competition, but we have also been given the opportunity to actively contribute to a worthy cause

says Antonio. « We found Prof Ollert’s approach particularly fascinating, since he aims to develop a vaccine using manufactured proteins resembling parts of the SARS-CoV-2 virus for antibody generation, rather than using the coronavirus itself. We are extremely grateful to the LTS for their guidance and support and for this truly amazing experience!« , he adds. 

We were very glad to learn that our project had raised the interest and curiosity of these two bright students. Their generous gesture further proves that we need to keep investing in young generations to help them nurture their passion for science and technology

concludes Prof Markus Ollert, Principal Investigator of the vaccine-development project and Director of the LIH Department of Infection and Immunity (DII).